Welwaze Medical, Inc.

Welwaze Medical, Inc. is a health technology company dedicated to preventing breast cancer deaths through innovative medical devices. The company focuses on enhancing breast health care management by developing non-invasive technologies that improve early detection of breast abnormalities. Their mission is to empower individuals and healthcare professionals to achieve better health outcomes, particularly in women's breast healthcare. The flagship product, Celbrea®, is an FDA-cleared breast thermal activity indicator that detects elevated surface temperatures as a biomarker for early breast disease detection. It uses a biocompatible multilayer pad with over 1,000 sensors to measure temperature differences on the breast surface, providing results within 15 minutes. Welwaze Medical is also developing a companion mobile app that utilizes AI and machine learning to analyze thermal images and offer risk profiling and reporting. Welwaze Medical primarily serves healthcare professionals and institutions involved in breast health management, aiming to support routine screening and diagnostic protocols. The company has conducted extensive clinical trials to validate the efficacy of Celbrea® and is led by a multidisciplinary team of experts.

• Employees 23
• Founded 2016